“Appropriate” secondary prevention at baseline and outcome
Subjects (n) | Baseline | Outcome | Difference | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | (%) | n | (%) | % | (95% CI) | ||||||
Aspirin management | |||||||||||
Intervention | 575 | 399 | (69.4) | 466 | (81.0) | 11.7 | (8.5 to 14.8) | ||||
Control | 562 | 355 | (63.2) | 373 | (66.4) | 3.2 | (0.5 to 5.9) | ||||
Blood pressure management | |||||||||||
Intervention | 593 | 514 | (86.7) | 572 | (96.5) | 9.8 | (7.0 to 12.6) | ||||
Control | 580 | 509 | (87.8) | 510 | (87.9) | 0.2 | (−2.7 to 3.0) | ||||
Lipid management | |||||||||||
Intervention | 593 | 71 | (12.0) | 244 | (41.1) | 29.2 | (25.1 to 33.3) | ||||
Control | 580 | 80 | (13.8) | 125 | (21.6) | 7.8 | (4.3 to 11.2) | ||||
Moderate physical activity | |||||||||||
Intervention | 587 | 221 | (37.6) | 247 | (42.1) | 4.4 | (0.9 to 7.9) | ||||
Control | 568 | 183 | (32.2) | 177 | (31.2) | −1.1 | (−4.6 to 2.5) | ||||
Low fat diet | |||||||||||
Intervention | 480 | 235 | (49.0) | 271 | (56.5) | 7.5 | (2.4 to 12.6) | ||||
Control | 465 | 226 | (48.6) | 226 | (48.6) | 0.0 | (−4.6 to 4.6) | ||||
Non-smoking | |||||||||||
Intervention | 584 | 482 | (82.5) | 483 | (82.7) | 0.2 | (−1.9 to 2.3) | ||||
Control | 568 | 470 | (82.7) | 481 | (84.7) | 1.9 | (−0.3 to 4.1) |
CI, confidence interval.